Represented Niam in the establishment of Niam Fund IV, an opportunistic fund with investors consisting of international financial investors, including the largest international pension funds. The work was lead by attorneys at the Stockholm office, assisted by attorneys at the firm’s U.S. offices. Once established, we acted for Niam Fund IV when it invested approximately seven billion kronor in a portfolio of 41 properties, situated in Stockholm, Göteborg, Malmö, Lund and Uppsala.

Experience Center

Match our Experience to Your Needs

View All Case Studies

Experience Highlights

Biopolymer Engineering Inc. v. Immunocorp
The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by more
Multifaceted debt refinancing transaction for Interface Inc.
Represented Interface Inc., a worldwide leader in the design, production and sales of modular carpet, in its approximately $300 million public debt more
Restrictive covenant litigation for EyeWonder in New York federal court and in arbitration

The firm served as lead counsel for EyeWonder, Inc. in the Southern District of New York to enforce restrictive covenants when its former head of more

Expert witness in litigation for pharmaceutical company
Expert witness for global veterinary medicine corporation in litigation involving an animal vaccine. more